nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Akt plays an important role in breast cancer cell chemotaxis to CXCL12
|
Zhao, Ming |
|
2007 |
110 |
2 |
p. 211-222 |
artikel |
2 |
Antibodies to 46-kDa retinal antigen in a patient with breast carcinoma and cancer-associated retinopathy
|
Ejma, Maria |
|
2007 |
110 |
2 |
p. 269-271 |
artikel |
3 |
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy
|
Johnston, Stephen R. D. |
|
2007 |
110 |
2 |
p. 327-335 |
artikel |
4 |
A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer
|
Garin, August |
|
2007 |
110 |
2 |
p. 309-315 |
artikel |
5 |
Breast cancer in elderly women. Optimizing the treatment
|
Gennari, Roberto |
|
2007 |
110 |
2 |
p. 199-209 |
artikel |
6 |
CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk
|
Han, Sohee |
|
2007 |
110 |
2 |
p. 387-393 |
artikel |
7 |
Central carbon metabolism in the progression of mammary carcinoma
|
Richardson, Adam D. |
|
2007 |
110 |
2 |
p. 297-307 |
artikel |
8 |
Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variants
|
Pettigrew, Christopher A. |
|
2007 |
110 |
2 |
p. 227-234 |
artikel |
9 |
Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice
|
Wang, Wen-Bo |
|
2007 |
110 |
2 |
p. 283-295 |
artikel |
10 |
Consensus genes of the literature to predict breast cancer recurrence
|
Lauss, Martin |
|
2007 |
110 |
2 |
p. 235-244 |
artikel |
11 |
Differential gene expression profile in breast cancer-derived stromal fibroblasts
|
Singer, Christian F. |
|
2007 |
110 |
2 |
p. 273-281 |
artikel |
12 |
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis
|
Savage, Kay |
|
2007 |
110 |
2 |
p. 245-256 |
artikel |
13 |
Does high surgeon and hospital surgical volume raise the five-year survival rate for breast cancer? A population-based study
|
Chen, Chin-Shyan |
|
2007 |
110 |
2 |
p. 349-356 |
artikel |
14 |
Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors
|
Faggioli, Francesca |
|
2007 |
110 |
2 |
p. 223-226 |
artikel |
15 |
Extracellular matrix, Rac1 signaling, and estrogen-induced proliferation in MCF-7 breast cancer cells
|
Xie, J-W. |
|
2007 |
110 |
2 |
p. 257-268 |
artikel |
16 |
Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans
|
Huo, Dezheng |
|
2007 |
110 |
2 |
p. 367-376 |
artikel |
17 |
Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged ≤55 years
|
Lu, Jiachun |
|
2007 |
110 |
2 |
p. 357-366 |
artikel |
18 |
G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history
|
Anagnostopoulos, Theodore |
|
2007 |
110 |
2 |
p. 377-385 |
artikel |
19 |
I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer
|
Rożnowski, Krzysztof |
|
2007 |
110 |
2 |
p. 343-348 |
artikel |
20 |
Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial
|
Dayes, Ian S. |
|
2007 |
110 |
2 |
p. 337-342 |
artikel |
21 |
Standardization of pathologic complete response rates in breast cancer treatment
|
Knauer, Michael |
|
2007 |
110 |
2 |
p. 395-396 |
artikel |
22 |
The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study
|
Golouh, Rastko |
|
2007 |
110 |
2 |
p. 317-326 |
artikel |